Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region
Eleonora Del Prete, Alessio Francesconi, Giovanni Palermo, et al.
Journal of Neurology (2020) Vol. 268, Iss. 4, pp. 1179-1187
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance
Aneesha Achar, Chaitali Ghosh
Cells (2020) Vol. 9, Iss. 11, pp. 2360-2360
Open Access | Times Cited: 150
Parkinson’s Disease and the COVID-19 Pandemic
Conor Fearon, Alfonso Fasano
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 2, pp. 431-444
Open Access | Times Cited: 84
The impact of Parkinson's disease on manifestations and outcomes of Covid‐19 patients: A systematic review and meta‐analysis
Amr Ehab El‐Qushayri, Sherief Ghozy, Abdullah Reda, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 62
Alzheimer’s and Parkinson’s Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study
Yizhou Yu, Marco Travaglio, Rebeka Popovic, et al.
Geriatrics (2021) Vol. 6, Iss. 1, pp. 10-10
Open Access | Times Cited: 59
Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment
Jinyang Zhao, Fan Xia, Xue Jiao, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 10
Risk of Hospitalization and Death for COVID ‐19 in People with Parkinson's Disease or Parkinsonism
Luca Vignatelli, Corrado Zenesini, Laura Maria Beatrice Belotti, et al.
Movement Disorders (2020) Vol. 36, Iss. 1, pp. 1-10
Open Access | Times Cited: 54
Presentation and management of anxiety in individuals with acute symptomatic or asymptomatic COVID-19 infection, and in the post-COVID-19 recovery phase
Genoveva Uzunova, Stefano Pallanti, Eric Hollander
International Journal of Psychiatry in Clinical Practice (2021) Vol. 25, Iss. 2, pp. 115-131
Closed Access | Times Cited: 44
COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly
Delfina Janiri, Martina Petracca, Lorenzo Moccia, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 44
Clinical Profiles and Mortality of COVID‐19 Inpatients with Parkinson's Disease in Germany
Raphael Scherbaum, Eun Hae Kwon, Daniel Richter, et al.
Movement Disorders (2021) Vol. 36, Iss. 5, pp. 1049-1057
Open Access | Times Cited: 39
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic
Elisa Montanaro, Carlo Alberto Artusi, Cristina Rosano, et al.
Neurological Sciences (2021) Vol. 43, Iss. 1, pp. 341-348
Open Access | Times Cited: 38
Social and psychological impact of the COVID-19 pandemic on people with Parkinson's disease: a scoping review
Samantha K. Brooks, Dale Weston, Neil Greenberg
Public Health (2021) Vol. 199, pp. 77-86
Open Access | Times Cited: 37
Covid-19 and Parkinson’s disease: an overview
Sandy Maria Cartella, Carmen Terranova, Vincent Rizzo, et al.
Journal of Neurology (2021) Vol. 268, Iss. 12, pp. 4415-4421
Open Access | Times Cited: 34
COVID-19 and Parkinson’s Disease: What Do We Know So Far?
Carlo Alberto Artusi, Alberto Romagnolo, Claudia Ledda, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 2, pp. 445-454
Open Access | Times Cited: 33
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
Lea Krey, Meret K. Huber, Günter U. Höglinger, et al.
Brain Sciences (2021) Vol. 11, Iss. 12, pp. 1654-1654
Open Access | Times Cited: 29
A bibliometric analysis of COVID-19 publications in neurology by using the visual mapping method
Qian Zhang, Li J, Ling Weng
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 22
Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism
Valentina Leta, Iro Boura, Daniel J. van Wamelen, et al.
International review of neurobiology (2022), pp. 63-89
Open Access | Times Cited: 21
RETRACTED ARTICLE: Parkinson’s disease detection using modified ResNeXt deep learning model from brain MRI images
Battula Balnarsaiah, B. Ashok Nayak, G. Spica Sujeetha, et al.
Soft Computing (2023) Vol. 27, Iss. 16, pp. 11905-11914
Closed Access | Times Cited: 11
COVID-19 social distancing: negative effects on people with Parkinson disease and their associations with confidence for self-management
Galit Yogev‐Seligmann, Michal Kafri
BMC Neurology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Parkinson’s disease and COVID-19: a systematic review and meta-analysis
Reza Jalili Khoshnood, Alireza Zali, Arash Tafreshinejad, et al.
Neurological Sciences (2021) Vol. 43, Iss. 2, pp. 775-783
Open Access | Times Cited: 25
Social isolation, loneliness and mental health sequelae of the Covid-19 pandemic in Parkinson's disease
Bradley McDaniels, Indu Subramanian
International review of neurobiology (2022), pp. 197-227
Open Access | Times Cited: 17
The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study
Fawzi Babtain, Abdulaziz Bajafar, Ohoud Nazmi, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 65, pp. 103985-103985
Open Access | Times Cited: 17
The impact of the quarantine period due to the pandemic on the severity of Parkinson's disease and the quality of life of Parkinson's patients
Fatemeh Rafizadeh, Masoud Saadat Fakhr, Elham Davtalab Esmaeili, et al.
Clinics (2025) Vol. 80, pp. 100605-100605
Open Access
Factors associated with COVID‐19 in people with Parkinson’s disease: a systematic review and meta‐analysis
Diego Chambergo‐Michilot, Shamir Barros‐Sevillano, Oscar Orlando Rivera Torrejón, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 10, pp. 3467-3477
Open Access | Times Cited: 22
COVID-19 and Parkinson’s disease: a systematic review and meta-analysis
Maryam Afraie, Ghobad Moradi, Pardis Mohammadzedeh, et al.
Acta Neurologica Belgica (2022) Vol. 123, Iss. 4, pp. 1209-1223
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top